Genate Prenatal Genate is the first gene-guided prenatal precision nutrition test that links genetics to prenatal nutrition decisions, presenting a direct upsell opportunity for prenatal care providers, obstetrics clinics, and maternal health services seeking personalized nutrition guidance.

Nutrigenomics Growth SNP Therapeutics targets 317 SNPs across five metabolic pathways to assess nutrient deficiency risk, offering a scalable genetic testing platform that can be positioned to clinics, labs, and wellness programs aiming to customize dietary interventions for at-risk populations.

At Home Access The easy at home saliva test enables convenient sample collection for patients, creating sales angles with telehealth partners, D2C wellness brands, and pediatric or maternal health channels that prioritize minimal in-person visits.

Strategic Partnerships With recognizable leadership in nutrition research and a proven track record in launching prenatal nutrition products, there are opportunities to partner with universities, research institutes, and health networks to expand validation studies and co-marketing initiatives.

Revenue Opportunity Current revenue range indicates a growing early-stage biotech enablement space; sales efforts can target specialty clinics, genetics-focused laboratories, and nutraceutical distributors seeking differentiated precision nutrition testing for prenatal and chronic disease risk management.